Krebs Biochemicals & Industries Company Description

Krebs Biochemicals & Industries Limited engages in the manufacture of active pharmaceutical ingredients in India.

It offers androstenedione for steroid intermediate indications, as well as lovastatin and simvastatin for anti-cholesterol applications.

The company also develops amlodipine and telmisartan for anti-hypertension; cetirizine for antihistamine; orlistat for anti-obesity; serratiopeptidase for anti-inflammatory; and phenylephrine for cold and cough.

In addition, it provides contract manufacturing services for large pharmaceutical and multinational companies.

The company was incorporated in 1991 and is based in Visakhapatnam, India.

Krebs Biochemicals & Industries Limited

Country	India
Founded	1991
Industry	Drug Manufacturers - Specialty & Generic
Sector	Healthcare
Employees	142
CEO	Manish Jain

Contact Details

Address: Kothapalli Village Visakhapatnam, 531031 India
Phone	91 91 2114 4984
Website	krebsbiochem.com

Stock Details

Ticker Symbol	KREBSBIO
Exchange	National Stock Exchange of India
Fiscal Year	April - March
Reporting Currency	INR
ISIN Number	INE268B01013
SIC Code	2833

Key Executives

Name	Position
Manish Kumar Jain	MD, Chief Executive Officer and Director
Dr. Ravi Ravindranath Tagore	Founder and Non-Executive Chairman
Rakesh R. Kalbate	Company Secretary and Compliance Officer
Ritesh Jain	Chief Financial Officer